Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shoulder, knee implant reclassification petitions being crafted by orthopedic coalition.

This article was originally published in The Gray Sheet

Executive Summary

KNEE, SHOULDER IMPLANT DOWNCLASSIFICATION PETITIONS are under development by a coalition of orthopedics groups including the American Academy of Orthopedic Surgeons, the American Orthopedic Association, the American Society for Testing and Materials, the Orthopedic Surgical Manufacturers Association and the Orthopedic Research Society. Informally known as the "Device Forum," the group hopes to present preliminary drafts of the petitions -- which will seek to move certain knee and shoulder implants from Class III to Class II -- to the FDA Office of Device Evaluation's Orthopedic Devices Branch at the end of April.

You may also be interested in...



Orthopedic Implant Classification Scheme Proposed To HHS Secretary’s Panel

FDA's medical device classification system should include a separate category for non-life-threatening implants such as prostheses, according to the American Academy of Orthopaedic Surgeons

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel